Stockscreener 앱 받기
2.67
3.89%
0.10
시간 외 거래:
2.61
-0.06
-2.25%
전일 마감가:
$2.57
열려 있는:
$2.52
하루 거래량:
51,795
Relative Volume:
0.07
시가총액:
$3.84M
수익:
$1.03M
순이익/손실:
$-11.10M
주가수익비율:
-0.0404
EPS:
-66.0832
순현금흐름:
$-8.21M
1주 성능:
+3.09%
1개월 성능:
-21.01%
6개월 성능:
-82.53%
1년 성능:
-93.09%
1일 변동 폭
$2.52
$2.6999
1주일 범위
$2.39
$2.78
52주 변동 폭
$2.39
$127.20
Ispecimen Inc Stock (ISPC) Company Profile
명칭
Ispecimen Inc
전화
781-301-6700
주소
8 CABOT ROAD, WOBURN
Compare ISPC vs TMO, DHR, IDXX, A, NTRA
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
2.67 | 3.69M | 1.03M | -11.10M | -8.21M | -66.08 |
TMO
Thermo Fisher Scientific Inc
|
513.03 | 187.95B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
196.19 | 136.75B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
551.50 | 43.78B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.01 | 38.27B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
261.91 | 37.34B | 2.50B | -226.32M | 71.51M | -1.6412 |
Ispecimen Inc 주식(ISPC)의 최신 뉴스
iSpecimen Inc Actuals & Estimates (NASDAQ:ISPC) - TradingView
ISpecimen Offering Up to 1.54M Shrs - Moomoo
iSpecimen (NASDAQ: ISPC) plans $4M common stock and pre-funded warrant sale - Stock Titan
iSpecimen Inc (ISPC) Institutional Confidence - TradingKey
iSpecimen Stockweekly review and sector backdrop - Ad-hoc-news.de
ISPC Should I Buy - Intellectia AI
iSpecimen | 8-K: Current report - Moomoo
iSpecimen Inc (ISPC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
iSpecimen Inc (ISPC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
iSpecimen Inc (ISPC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
iSpecimen Inc (ISPC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
iSpecimen Inc (ISPC) Valuation: PE, PB & Fair Value Analysis - TradingKey
[EFFECT] iSpecimen Inc. SEC Filing - Stock Titan
iSpecimen Inc (ISPC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
iSpecimen Inc (ISPC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iSpecimen Inc (ISPC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
iSpecimen Receives Nasdaq Noncompliance Notice, Listing at Risk - TipRanks
iSpecimen Q3 2024 Earnings: Significant EPS Miss Amidst Limited Financial DisclosureEarnings Miss Streak - newsline.com
iSpecimen Inc Stock (US46536T1016): shares in focus after quiet session - AD HOC NEWS
ISPC Q3 2024 Earnings: Massive EPS Miss with 983.59% Negative SurpriseStrong Earnings Momentum - newsline.com
ISPC Q3 2024 Earnings: Widely Missed EPS Expectations, Stock Rises 6%Earnings Call Q&A - newsline.com
iSpecimen (NASDAQ: ISPC) registers 488,290 shares from May 2026 placement - Stock Titan
MSN Money - MSN
$iSpecimen (ISPC.US)$ so far so good - Moomoo
iSpecimen Inc. Files Form 8-K with SEC: Company Details, NASDAQ Listing, and Emerging Growth Status (May 29, 2026) - Minichart
iSpecimen Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
iSpecimen (NASDAQ: ISPC) falls below Nasdaq equity listing requirement - Stock Titan
iSpecimen Inc. Files Form 8-K Announcing Approval of 2025 Stock Incentive Plan and Key Company Details - Minichart
ISPC Q3 2024 Earnings: Significant EPS Miss amidst Operational ChallengesProfit Recovery Report - newsline.com
What's Driving iSpecimen's Recent Stock Surge - Kavout
iSpecimen Shareholders Approve Director, Auditor and Incentive Plan - TipRanks
iSpecimen (ISPC) investors approve director, auditor and 2025 stock incentive plan - Stock Titan
iSpecimen Inc.Common Stock (Nasdaq:ISPC) Stock Quote - FinancialContent
iSpecimen Inc. (ISPC) Q3 2024 Earnings: Massive EPS Miss Reflects Operational ChallengesSegment Revenue Breakdown - The Legal Advocate
iSpecimen trades near lows as cash test and vote loom - Bez Kabli
iSpecimen Inc. (ISPC) Holds Steady Near Key Support as Sector Headwinds LingerMean Reversion Trade - The Legal Advocate
iSpecimen Inc. (ISPC) Q3 2024 Earnings: Significant EPS Miss Amidst Operational ChallengesHigh Growth Earnings - newsline.com
iSpecimen Inc. (ISPC) Slips 2% as Stock Tests Support Near $3.21Fast Moving Stocks - The Legal Advocate
iSpecimen Inc (ISPC) Stock Price, Quote, News & History - Benzinga
iSpecimen (ISPC) Faces Renewed Selling Pressure, Tests Key Support Near $3.28Safe Entry Stocks - newsline.com
iSpecimen stock (US46536T1016): Company update still needs a dated catalyst - AD HOC NEWS
iSpecimen Inc stock (US46536T1016): Clinical sample platform faces a fresh investor spotlight - AD HOC NEWS
iSpecimen Inc. Q1 2026 10-Q Report: Financial Performance, Going Concern, and Reverse Stock Split Overview - Minichart
iSpecimen Inc. 1Q 2026: Revenue $156.01K, EPS ($6.66) — 10-Q Summary - TradingView
ISpecimen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
What is iSpecimen Inc. stock? - Bitget
iSpecimen (NASDAQ: ISPC) posts Q1 2026 loss and warns of going-concern risk - Stock Titan
iSpecimen (NASDAQ: ISPC) notifies SEC of late 10-Q filing - Stock Titan
iSpecimen stock (US46536T1016): capital raise and Nasdaq compliance in focus - AD HOC NEWS
iSpecimen Inc. Announces $2.5 Million Private Placement to Support Marketplace Growth and Marketing Efforts - Minichart
iSpecimen Regains Nasdaq Compliance and Raises New Capital - TipRanks
Ispecimen Inc (ISPC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.76%
0.62%
자본화:
|
볼륨(24시간):